T1	Participants 0 19	Bronchial carcinoma
T2	Participants 138 179	inoperable patients with advanced disease
T3	Participants 182 308	Forty-eight bronchial carcinoma patients in clinicoanatomical stage 4 of the disease (advanced disease) were randomly assigned
